Literature DB >> 21168411

The active site protonation states of perdeuterated Toho-1 β-lactamase determined by neutron diffraction support a role for Glu166 as the general base in acylation.

Stephen J Tomanicek1, Kathy K Wang, Kevin L Weiss, Matthew P Blakeley, Jonathan Cooper, Yu Chen, Leighton Coates.   

Abstract

Room temperature neutron diffraction data of the fully perdeuterated Toho-1 R274N/R276N double mutant β-lactamase in the apo form were used to visualize deuterium atoms within the active site of the enzyme. This perdeuterated neutron structure of the Toho-1 R274N/R276N reveals the clearest picture yet of the ground-state active site protonation states and the complete hydrogen-bonding network in a β-lactamase enzyme. The ground-state active site protonation states detailed in this neutron diffraction study are consistent with previous high-resolution X-ray studies that support the role of Glu166 as the general base during the acylation reaction in the class A β-lactamase reaction pathway.
Copyright © 2010 Federation of European Biochemical Societies. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168411     DOI: 10.1016/j.febslet.2010.12.017

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Neutron and X-ray crystal structures of a perdeuterated enzyme inhibitor complex reveal the catalytic proton network of the Toho-1 β-lactamase for the acylation reaction.

Authors:  Stephen J Tomanicek; Robert F Standaert; Kevin L Weiss; Andreas Ostermann; Tobias E Schrader; Joseph D Ng; Leighton Coates
Journal:  J Biol Chem       Date:  2012-12-18       Impact factor: 5.157

2.  Excess positional mutual information predicts both local and allosteric mutations affecting beta lactamase drug resistance.

Authors:  George A Cortina; Peter M Kasson
Journal:  Bioinformatics       Date:  2016-07-27       Impact factor: 6.937

3.  Frequent side chain methyl carbon-oxygen hydrogen bonding in proteins revealed by computational and stereochemical analysis of neutron structures.

Authors:  Joseph D Yesselman; Scott Horowitz; Charles L Brooks; Raymond C Trievel
Journal:  Proteins       Date:  2015-01-21

4.  Preliminary neutron crystallographic study of human transthyretin.

Authors:  Melina Haupt; Matthew P Blakeley; Susana C M Teixeira; Sax A Mason; Edward P Mitchell; Jonathan B Cooper; V Trevor Forsyth
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-27

5.  Probing the role of the conserved residue Glu166 in a class A β-lactamase using neutron and X-ray protein crystallography.

Authors:  Patricia S Langan; Brendan Sullivan; Kevin L Weiss; Leighton Coates
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-01-24       Impact factor: 7.652

6.  QM/MM modeling of class A β-lactamases reveals distinct acylation pathways for ampicillin and cefalexin.

Authors:  Zilin Song; Francesco Trozzi; Timothy Palzkill; Peng Tao
Journal:  Org Biomol Chem       Date:  2021-11-03       Impact factor: 3.876

7.  Direct observation of hydrogen atom dynamics and interactions by ultrahigh resolution neutron protein crystallography.

Authors:  Julian C-H Chen; B Leif Hanson; S Zoë Fisher; Paul Langan; Andrey Y Kovalevsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

8.  A quantitative measure of electrostatic perturbation in holo and apo enzymes induced by structural changes.

Authors:  Sandeep Chakraborty
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

9.  Enumerating pathways of proton abstraction based on a spatial and electrostatic analysis of residues in the catalytic site.

Authors:  Sandeep Chakraborty
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

10.  Binding site asymmetry in human transthyretin: insights from a joint neutron and X-ray crystallographic analysis using perdeuterated protein.

Authors:  Melina Haupt; Matthew P Blakeley; Stuart J Fisher; Sax A Mason; Jon B Cooper; Edward P Mitchell; V Trevor Forsyth
Journal:  IUCrJ       Date:  2014-10-21       Impact factor: 4.769

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.